BOVIMAST DC, 500 MG CLOXACILLIN/SYRINGE, INTRAMAMMARY SUSPENSION

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

CLOXACILLIN BENZATHINE

Commercializzato da:

Cross Vetpharm Group Limited

Codice ATC:

QJ51CF

INN (Nome Internazionale):

CLOXACILLIN BENZATHINE

Dosaggio:

500 mg/syringe

Forma farmaceutica:

intramammary Suspension

Tipo di ricetta:

POM

Gruppo terapeutico:

Bovine

Area terapeutica:

Beta-lactamase resistant penicillins

Indicazioni terapeutiche:

Antibacterial

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2004-07-08

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovimast DC, 500 mg cloxacillin/syringe, Intramammary suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 3 g syringe contains:
ACTIVE SUBSTANCE:
Cloxacillin (as Cloxacillin Benzathine)
500 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Intramammary suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cows
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For routine use in cows at drying off, to treat existing intramammary infections and to assist in preventing new infections
occurring during the dry period. Bovimast DC contains cloxacillin which is active against the following major pathogens
associated with mastitis: Penicillin resistant and sensitive _Staphylococci _spp., _Micrococci, Streptococcus agalactiae _and
_Corynebacterium _spp.
4.3 CONTRAINDICATIONS
Do not use in lactating cows.
Do not use within 28 days of calving.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 11/07/2012_
_CRN 7013024_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target
bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Penicillin and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact.
Hypersensitivity to penicillin may lead to cross sensitivity to cephalo